Instead of focusing only on short-term tolerability, providers should evaluate the longer trajectory of gastrointestinal effects
Participants are assessed before entering the trial and monitored during treatment
Moreover, chronic treatment with GLP-1 RA has been shown to reduce blood pressure and plasma levels of atherogenic lipoproteins, potentially resulting in a better hemodynamic profile and in a lower coronary atherosclerotic burden when AMI occurs [31,32,33]
*FOR 18.5% AVERAGE WEIGHT LOSS FOR PROGRAM MEMBERS SOURCE: Reflects data from clients who implemented CVS Weight Management program in 2024, showing average weight loss among engaged members who have been on anti-obesity medication for one year
These medications are becoming increasingly prescribed for both weight loss and type 2 diabetes management, can be significant medical expenses that may qualify for FSA/HSA reimbursement
The plateau effect is temporarymost patients experience progressive weight loss when they continue consistent treatment through months 2 and 3